Olaparib induced a reduction of CD117+/CD123+ MDS cells together with an increase of mature CD11b+/CD16+ cells that reached statistically significance at the concentration of 10 μM (Figure 4C). The gene discussed is KIT; the disease is myelodysplastic syndrome.